Under expert medical guidance, BPC-157 is considered to have a strong safety profile
The scientific studies of these experimental drugs were never large enough or long enough to establish a clear safety profile, so all we are left with are vague reassurances from tiny studies and testimonials from YouTubers and TikTokers
Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD
The burning in diabetic neuropathy is characteristically bilateral, symmetric, begins at the toes and ball of foot, and is worst at night when activity-generated sensory input stops competing with the pain signal
At The Center, we offer a variety of IM injections in addition to Semaglutide with B12 for weight loss, including NAD+ and Vitamin B12
For individuals seeking FDA-approved treatments, guaranteed outcomes, or immediate acute injury intervention, BPC-157 is not the appropriate choice